{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,25]],"date-time":"2026-08-25T18:45:50Z","timestamp":1787683550405,"version":"build-2784847793"},"reference-count":39,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2018,6,1]],"date-time":"2018-06-01T00:00:00Z","timestamp":1527811200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2018,6,1]],"date-time":"2018-06-01T00:00:00Z","timestamp":1527811200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["canadianjournalofophthalmology.ca","clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Canadian Journal of Ophthalmology"],"published-print":{"date-parts":[[2018,6]]},"DOI":"10.1016\/j.jcjo.2017.09.007","type":"journal-article","created":{"date-parts":[[2017,11,24]],"date-time":"2017-11-24T02:17:27Z","timestamp":1511489847000},"page":"266-271","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":12,"title":["Serum drops for ocular surface disease: national survey of Canadian cornea specialists"],"prefix":"10.1016","volume":"53","author":[{"given":"Michael","family":"Marchand","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mona","family":"Harissi-Dagher","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marc","family":"Germain","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paul","family":"Thompson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marie-Claude","family":"Robert","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jcjo.2017.09.007_bib1","doi-asserted-by":"crossref","first-page":"1115","DOI":"10.1016\/j.ophtha.2003.10.019","article-title":"Autologous serum application in the treatment of neurotrophic keratopathy","volume":"111","author":"Matsumoto","year":"2004","journal-title":"Ophthalmology"},{"key":"10.1016\/j.jcjo.2017.09.007_bib2","doi-asserted-by":"crossref","first-page":"579","DOI":"10.1038\/sj.bmt.1703862","article-title":"Autologous serum eye drops for the treatment of severe dry eye in patients with chronic graft-versus-host disease","volume":"31","author":"Ogawa","year":"2003","journal-title":"Bone Marrow Transplant"},{"key":"10.1016\/j.jcjo.2017.09.007_bib3","doi-asserted-by":"crossref","first-page":"390","DOI":"10.1136\/bjo.83.4.390","article-title":"Treatment of dry eye by autologous serum application in Sjogren\u2019s syndrome","volume":"83","author":"Tsubota","year":"1999","journal-title":"Br J Ophthalmol"},{"key":"10.1016\/j.jcjo.2017.09.007_bib4","doi-asserted-by":"crossref","first-page":"609","DOI":"10.1038\/sj.eye.6700721","article-title":"The use of autologous serum tears in persistent corneal epithelial defects","volume":"18","author":"Young","year":"2004","journal-title":"Eye"},{"key":"10.1016\/j.jcjo.2017.09.007_bib5","doi-asserted-by":"crossref","first-page":"1467","DOI":"10.1136\/bjo.2004.044347","article-title":"Autologous serum eye drops for ocular surface disorders","volume":"88","author":"Geerling","year":"2004","journal-title":"Br J Ophthalmol"},{"key":"10.1016\/j.jcjo.2017.09.007_bib6","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1517\/14656566.2010.518612","article-title":"Pharmacotherapy of dry eye","volume":"12","author":"Dogru","year":"2011","journal-title":"Expert Opin Pharmacother"},{"key":"10.1016\/j.jcjo.2017.09.007_bib7","doi-asserted-by":"crossref","first-page":"647","DOI":"10.1136\/bjo.2003.026211","article-title":"Comparison of autologous serum eye drops with conventional therapy in a randomised controlled crossover trial for ocular surface disease","volume":"88","author":"Noble","year":"2004","journal-title":"Br J Ophthalmol"},{"key":"10.1016\/j.jcjo.2017.09.007_bib8","doi-asserted-by":"crossref","first-page":"619","DOI":"10.1007\/s00417-014-2599-1","article-title":"The efficacy of autologous serum eye drops for severe dry eye syndrome: a randomized double-blind crossover study","volume":"252","author":"Celebi","year":"2014","journal-title":"Graefes Arch Clin Exp Ophthalmol"},{"key":"10.1016\/j.jcjo.2017.09.007_bib9","doi-asserted-by":"crossref","first-page":"1104","DOI":"10.1097\/ICO.0b013e3181a2a7f6","article-title":"Autologous serum 50% eyedrops in the treatment of persistent corneal epithelial defects","volume":"28","author":"Jeng","year":"2009","journal-title":"Cornea"},{"key":"10.1016\/j.jcjo.2017.09.007_bib10","first-page":"537","article-title":"Treatment of persistent epithelial defects using autologous serum application","volume":"79","author":"Alvarado Valero","year":"2004","journal-title":"Arch Soc Esp Oftalmol"},{"key":"10.1016\/j.jcjo.2017.09.007_bib11","doi-asserted-by":"crossref","first-page":"720","DOI":"10.1055\/s-2001-18663","article-title":"Autologous serum for otherwise therapy resistant corneal epithelial defects\u2014prospective report on the first 70 eyes","volume":"218","author":"Ferreira de Souza","year":"2001","journal-title":"Klin Monbl Augenheilkd"},{"key":"10.1016\/j.jcjo.2017.09.007_bib12","doi-asserted-by":"crossref","first-page":"1245","DOI":"10.1097\/ICO.0000000000000271","article-title":"Long-term use of autologous serum 50% eye drops for the treatment of dry eye disease","volume":"33","author":"Hussain","year":"2014","journal-title":"Cornea"},{"key":"10.1016\/j.jcjo.2017.09.007_bib13","doi-asserted-by":"crossref","first-page":"21","DOI":"10.3109\/02713683.2013.824987","article-title":"The application of autologous serum eye drops in severe dry eye patients; subjective and objective parameters before and after treatment","volume":"39","author":"Jirsova","year":"2014","journal-title":"Curr Eye Res"},{"key":"10.1016\/j.jcjo.2017.09.007_bib14","doi-asserted-by":"crossref","first-page":"242","DOI":"10.1016\/j.ajo.2004.08.040","article-title":"The effect of autologous serum eyedrops in the treatment of severe dry eye disease: a prospective randomized case-control study","volume":"139","author":"Kojima","year":"2005","journal-title":"Am J Ophthalmol"},{"key":"10.1016\/j.jcjo.2017.09.007_bib15","doi-asserted-by":"crossref","first-page":"684","DOI":"10.3109\/02713683.2012.674609","article-title":"Randomized double-blind clinical trial of autologous serum versus artificial tears in dry eye syndrome","volume":"37","author":"Urzua","year":"2012","journal-title":"Curr Eye Res"},{"key":"10.1016\/j.jcjo.2017.09.007_bib16","doi-asserted-by":"crossref","first-page":"2438","DOI":"10.1167\/iovs.05-0876","article-title":"Corneal epitheliotrophic capacity of three different blood-derived preparations","volume":"47","author":"Liu","year":"2006","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"10.1016\/j.jcjo.2017.09.007_bib17","doi-asserted-by":"crossref","first-page":"717","DOI":"10.1111\/j.1442-9071.2008.01895.x","article-title":"Serum growth factor analysis in dry eye syndrome","volume":"36","author":"Bradley","year":"2008","journal-title":"Clin Exp Ophthalmol"},{"key":"10.1016\/j.jcjo.2017.09.007_bib18","doi-asserted-by":"crossref","first-page":"184","DOI":"10.1007\/BF02169794","article-title":"Epidermal growth factor is a constant component of normal human tear fluid","volume":"227","author":"Van Setten","year":"1989","journal-title":"Graefes Arch Clin Exp Ophthalmol"},{"key":"10.1016\/j.jcjo.2017.09.007_bib19","doi-asserted-by":"crossref","first-page":"1188","DOI":"10.1136\/bjo.85.10.1188","article-title":"Autologous serum eyedrops for dry eyes and epithelial defects: clinical and in vitro toxicity studies","volume":"85","author":"Poon","year":"2001","journal-title":"Br J Ophthalmol"},{"key":"10.1016\/j.jcjo.2017.09.007_bib20","doi-asserted-by":"crossref","first-page":"1984","DOI":"10.1016\/S0161-6420(99)90412-8","article-title":"Treatment of persistent corneal epithelial defect by autologous serum application","volume":"106","author":"Tsubota","year":"1999","journal-title":"Ophthalmology"},{"key":"10.1016\/j.jcjo.2017.09.007_bib21","doi-asserted-by":"crossref","first-page":"59","DOI":"10.3109\/08820538.2015.1114853","article-title":"Understanding neuropathic corneal pain\u2014gaps and current therapeutic approaches","volume":"31","author":"Goyal","year":"2016","journal-title":"Semin Ophthalmol"},{"key":"10.1016\/j.jcjo.2017.09.007_bib22","doi-asserted-by":"crossref","first-page":"250","DOI":"10.1016\/j.jtos.2015.01.005","article-title":"Autologous serum tears for treatment of photoallodynia in patients with corneal neuropathy: efficacy and evaluation with in vivo confocal microscopy","volume":"13","author":"Aggarwal","year":"2015","journal-title":"Ocul Surf"},{"key":"10.1016\/j.jcjo.2017.09.007_bib23","doi-asserted-by":"crossref","first-page":"e233","DOI":"10.1097\/OPX.0000000000000652","article-title":"Corneal neuralgia after LASIK","volume":"92","author":"Theophanous","year":"2015","journal-title":"Optom Vis Sci"},{"key":"10.1016\/j.jcjo.2017.09.007_bib24","doi-asserted-by":"crossref","first-page":"706","DOI":"10.1007\/s00417-004-1106-5","article-title":"An optimised protocol for the production of autologous serum eyedrops","volume":"243","author":"Liu","year":"2005","journal-title":"Graefes Arch Clin Exp Ophthalmol"},{"key":"10.1016\/j.jcjo.2017.09.007_bib25","doi-asserted-by":"crossref","first-page":"290","DOI":"10.1038\/sj.eye.6703079","article-title":"Allogeneic serum eye drops for the treatment of persistent corneal epithelial defect","volume":"23","author":"Chiang","year":"2009","journal-title":"Eye"},{"key":"10.1016\/j.jcjo.2017.09.007_bib26","doi-asserted-by":"crossref","first-page":"783","DOI":"10.1111\/aos.12386","article-title":"Ready-made allogeneic ABO-specific serum eye drops: production from regular male blood donors, clinical routine, safety and efficacy","volume":"92","author":"Harritsh\u00f8j","year":"2014","journal-title":"Acta Ophthalmol"},{"key":"10.1016\/j.jcjo.2017.09.007_bib27","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1016\/j.transci.2015.05.014","article-title":"Implementation of a standardised method for the production of allogeneic serum eye drops from regular blood donors in a Norwegian university hospital: some methodological aspects and clinical considerations","volume":"53","author":"Espinosa","year":"2015","journal-title":"Transfus Apher Sci"},{"key":"10.1016\/j.jcjo.2017.09.007_bib28","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1016\/j.transci.2015.05.017","article-title":"Autologous and allogeneic serum eye drops. The Dutch perspective","volume":"53","author":"van der Meer","year":"2015","journal-title":"Transfus Apher Sci"},{"key":"10.1016\/j.jcjo.2017.09.007_bib29","doi-asserted-by":"crossref","first-page":"164","DOI":"10.1016\/j.transci.2016.01.022","article-title":"Quality standards, safety and efficacy of blood-derived serum eye drops: a review","volume":"54","author":"van der Meer","year":"2016","journal-title":"Transfus Apher Sci"},{"key":"10.1016\/j.jcjo.2017.09.007_bib30","doi-asserted-by":"crossref","first-page":"861","DOI":"10.1097\/ICO.0b013e3180645cd7","article-title":"Allogeneic serum eye drops for the treatment of severe dry eye in patients with chronic graft-versus-host disease","volume":"26","author":"Chiang","year":"2007","journal-title":"Cornea"},{"key":"10.1016\/j.jcjo.2017.09.007_bib31","doi-asserted-by":"crossref","first-page":"479","DOI":"10.1089\/jop.2012.0002","article-title":"Allogeneic serum eye drops for the treatment of dry eye patients with chronic graft-versus-host disease","volume":"28","author":"Na","year":"2012","journal-title":"J Ocul Pharmacol Ther"},{"key":"10.1016\/j.jcjo.2017.09.007_bib32","doi-asserted-by":"crossref","first-page":"654","DOI":"10.1111\/aos.12801","article-title":"Improving the anti-inflammatory effect of serum eye drops using allogeneic serum permissive for regulatory T cell induction","volume":"93","author":"Stenwall","year":"2015","journal-title":"Acta Ophthalmol"},{"key":"10.1016\/j.jcjo.2017.09.007_bib33","doi-asserted-by":"crossref","first-page":"802","DOI":"10.1097\/00003226-200111000-00005","article-title":"Controlled study of the use of autologous serum in dry eye patients","volume":"20","author":"Tananuvat","year":"2001","journal-title":"Cornea"},{"key":"10.1016\/j.jcjo.2017.09.007_bib34","doi-asserted-by":"crossref","first-page":"1101","DOI":"10.1038\/sj.bmt.1702334","article-title":"GVHD dry eyes treated with autologous serum tears","volume":"25","author":"Rocha","year":"2000","journal-title":"Bone Marrow Transplant"},{"key":"10.1016\/j.jcjo.2017.09.007_bib35","doi-asserted-by":"crossref","first-page":"e15","DOI":"10.2105\/AJPH.2013.301823","article-title":"Prescription medication sharing: a systematic review of the literature","volume":"104","author":"Beyene","year":"2014","journal-title":"Am J Public Health"},{"key":"10.1016\/j.jcjo.2017.09.007_bib36","doi-asserted-by":"crossref","first-page":"200","DOI":"10.1097\/ICO.0b013e318186321e","article-title":"Time- and temperature-dependent stability of growth factor peptides in human autologous serum eye drops","volume":"28","author":"Bradley","year":"2009","journal-title":"Cornea"},{"key":"10.1016\/j.jcjo.2017.09.007_bib37","doi-asserted-by":"crossref","first-page":"1027","DOI":"10.1076\/ceyr.17.10.1027.5241","article-title":"Effect of storage on protein concentration of tear samples","volume":"17","author":"Sitaramamma","year":"1998","journal-title":"Curr Eye Res"},{"key":"10.1016\/j.jcjo.2017.09.007_bib38","doi-asserted-by":"crossref","first-page":"1313","DOI":"10.1097\/ICO.0b013e3182542085","article-title":"Stability of serum eye drops after storage of 6 months","volume":"31","author":"Fischer","year":"2012","journal-title":"Cornea"},{"key":"10.1016\/j.jcjo.2017.09.007_bib39","first-page":"705","article-title":"Sterility of non-preserved autologous serum drops for treatment of persistent corneal epithelial defects","volume":"101","author":"Sauer","year":"2004","journal-title":"Ophthalmologe"}],"container-title":["Canadian Journal of Ophthalmology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0008418217302211?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0008418217302211?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,13]],"date-time":"2025-09-13T20:07:10Z","timestamp":1757794030000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0008418217302211"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,6]]},"references-count":39,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2018,6]]}},"alternative-id":["S0008418217302211"],"URL":"https:\/\/doi.org\/10.1016\/j.jcjo.2017.09.007","relation":{},"ISSN":["0008-4182"],"issn-type":[{"value":"0008-4182","type":"print"}],"subject":[],"published":{"date-parts":[[2018,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Serum drops for ocular surface disease: national survey of Canadian cornea specialists","name":"articletitle","label":"Article Title"},{"value":"Canadian Journal of Ophthalmology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jcjo.2017.09.007","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2017 Canadian Ophthalmological Society. Published by Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}